Dental Study Announced By BioElectronics Corporation
BioElectronics Corporation, (Pink Sheets: BIEL), announced today that it has been selected as a recipient of the Maryland Industrial Partnership (MIPS) award for its' dental study, "Pulsed Electromagnetic Therapy for Healing." The dental study will be conducted by the University of Maryland Dental School. Dr. Sharon Gordon, DDS, MPH, PhD, Associate Professor Biomedical Sciences, Dental School, will be the University's Principal Investigator. Dr. Richard Cassie, DDS, Clinical Professor of Dentistry, New Jersey School of Dentistry and Medicine, will be the project manager and chief investigator.
"We are proud to have been chosen, by MIPS, to receive this award. The field of competition for this award is large, with an impressive array of scientific, bio-technology and technology candidates. We are also looking forward to working with Dr. Gordon and UMB on the dental study. The results of this study have the potential to generate a great deal of interest in the healing benefits of ActiPatch, not to mention opening up the dental market," said Andrew Whelan, President of BioElectronics Corporation.
"ActiPatch provides a unique therapy that is non-invasive and drug free. This dental study will provide the evidence based support and confirmation that the use of ActiPatch (PEMF therapy) will produce significant diminution of swelling and pain, and thereby will accelerate healing time. The clinical study will produce the definitive scientific
data needed to introduce ActiPatch to the dental practitioners," said Dr.Cassie.
